Kornitzer Capital Management Inc. KS lessened its position in shares of Danaher Co. (NYSE:DHR) by 0.8% in the first quarter, HoldingsChannel.com reports. The fund owned 58,039 shares of the conglomerate’s stock after selling 485 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Danaher were worth $7,662,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently modified their holdings of the company. Financial Consulate Inc. bought a new stake in shares of Danaher during the first quarter worth approximately $253,000. Eagle Asset Management Inc. lifted its holdings in shares of Danaher by 1.9% during the 1st quarter. Eagle Asset Management Inc. now owns 27,588 shares of the conglomerate’s stock worth $3,642,000 after acquiring an additional 515 shares during the last quarter. Gardiner Nancy B lifted its holdings in shares of Danaher by 4.4% during the 1st quarter. Gardiner Nancy B now owns 9,625 shares of the conglomerate’s stock worth $1,270,000 after acquiring an additional 405 shares during the last quarter. Intermede Investment Partners Ltd lifted its holdings in shares of Danaher by 13.7% during the 1st quarter. Intermede Investment Partners Ltd now owns 584,413 shares of the conglomerate’s stock worth $77,154,000 after acquiring an additional 70,513 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. lifted its holdings in shares of Danaher by 1.8% during the 1st quarter. Cookson Peirce & Co. Inc. now owns 4,710 shares of the conglomerate’s stock worth $622,000 after acquiring an additional 83 shares during the last quarter. Institutional investors own 77.57% of the company’s stock.
DHR has been the subject of a number of research analyst reports. Janney Montgomery Scott lifted their price objective on shares of Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a report on Wednesday, April 17th. Jefferies Financial Group lifted their price objective on shares of Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $140.00 price objective on shares of Danaher in a report on Monday, March 4th. Zacks Investment Research raised shares of Danaher from a “sell” rating to a “hold” rating in a report on Monday. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $138.00 price objective (up from $114.00) on shares of Danaher in a report on Thursday, February 28th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Danaher has a consensus rating of “Buy” and an average target price of $131.75.
Shares of NYSE:DHR opened at $131.34 on Friday. The firm has a market capitalization of $94.30 billion, a P/E ratio of 29.06, a price-to-earnings-growth ratio of 2.60 and a beta of 1.02. Danaher Co. has a 52 week low of $94.59 and a 52 week high of $134.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18.
Danaher (NYSE:DHR) last issued its earnings results on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The firm’s revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.99 EPS. As a group, equities analysts forecast that Danaher Co. will post 4.77 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date is Thursday, June 27th. Danaher’s payout ratio is presently 15.04%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: Futures Contract
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.